NRGN and Alzheimer disease: Ng is a post‐synaptic protein (Gerendasy & Sutcliffe, 1997) and a putative marker of synaptic loss in AD (Portelius et al, 2015), an event which may be closely linked to development of cognitive decline (Portelius et al, 2015).